Its mutations result in a loss of protein function, which is the basis of autosomal recessive genetic disorders. LRP2 is also mutated in many cancers—16% of colon and rectum adenocarcinoma, 19.7% of lung cancers and 9.3% of bladder cancers [10]. The gene discussed is LRP2; the disease is cancer.